Unicycive Therapeutics, Inc. (UNCY) - Winst- en verliesrekening per kwartaal

Home
UNCY
Financiële Gegevens

4.64 (USD) • At close July 2, 2025

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Omzet Numbers are in millions	0	0	0	0	0	-0.271	0	0	0.675	0	0.951	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0	0.134	0	0	0.284	0.082	0.079	0.078	0.045	0.002	0.001	0.002	0.002	0.001	0	0	0	0	0	0	0	0	0	0	0
Brutowinst Numbers are in millions	0	0	0	0	-0.284	-0.353	-0.079	-0.078	0.63	-0.002	0.95	-0.002	-0.002	-0.001	0	0	0	0	0	0	0	0	0	0	0
Brutowinstmarge Numbers are in millions	0	0	0	0	0	1.303	0	0	0.933	0	0.999	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	2.171	5.288	3.045	4.868	6.813	4.233	3.372	2.267	3.03	3.84	4.803	1.86	1.933	1.361	3.776	0.493	0.45	0.382	0.304	0.182	0.148	0.376	0.188	0.116	0.116
Algemene en administratieve kosten Numbers are in millions	5.818	3.973	3.206	2.533	2.391	2.08	2.566	2.055	1.847	1.485	1.702	1.776	1.604	1.391	0.939	0.286	0.281	0.335	0.322	0.154	0.194	0.325	0.293	0.275	0.275
Verkoop- en marketingkosten Numbers are in millions	0	0.284	0	0	-0.284	-0.082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	5.818	3.973	3.206	2.533	2.107	1.998	2.566	2.055	1.847	1.485	1.702	1.776	1.604	1.391	0.939	0.286	0.281	0.335	0.322	0.154	0.194	0.325	0.293	0.275	0.275
Overige kosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bedrijfskosten Numbers are in millions	7.989	9.261	6.251	7.401	8.92	6.231	5.938	4.322	4.877	5.325	6.505	3.636	3.537	2.752	4.715	0.779	0.731	0.717	0.626	0.336	0.342	0.701	0.544	0.391	0.391
Bedrijfsresultaat Numbers are in millions	-7.989	-9.261	-6.251	-7.401	-9.204	-6.313	-5.938	-4.322	-4.202	-5.325	-5.554	-3.636	-3.537	-2.752	-4.715	-0.779	-0.731	-0.717	-0.626	-0.336	-0.342	-0.701	-0.481	-0.391	-0.391
Bedrijfsresultaat ratio Numbers are in millions	0	0	0	0	0	23.295	0	0	-6.225	0	-5.84	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	8.559	-12.264	2.155	17.256	-11.759	-1.485	1.605	0.484	-10.373	-0.003	-0.003	0	0	0	-0.486	-0.321	-0.233	-0.163	-0.076	-0.002	-0.002	-0.001	-0.083	-0.059	-0.059
Inkomen voor belasting Numbers are in millions	0.57	-21.525	-4.096	9.855	-20.963	-7.798	-4.405	-3.838	-14.575	-5.328	-5.557	-3.636	-3.537	-2.752	-5.201	-1.1	-0.964	-0.88	-0.702	-0.338	-0.344	-0.702	-0.564	-0.45	-0.45
Inkomen voor belasting ratio Numbers are in millions	0	0	0	0	0	28.775	0	0	-21.593	0	-5.843	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0	-0.241	0	0	0.241	-10.53	-0.079	0.032	10.577	0.003	0.003	0.038	0.037	-0.412	0.431	-0.779	-0.019	-0.717	-0.626	-0.336	-0.342	-0.001	-0.083	-0.059	-0.059
Nettowinst Numbers are in millions	0.57	-21.525	-4.096	9.855	-20.963	-7.798	-4.405	-3.838	-25.152	-5.331	-5.56	-3.636	-3.537	-2.752	-5.201	-1.1	-0.964	-0.88	-0.702	-0.338	-0.344	-0.702	-0.564	-0.45	-0.45
Nettowinstmarge Numbers are in millions	0	0	0	0	0	28.775	0	0	-37.262	0	-5.846	0	0	0	0	0	0	0	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-0.05	-0.032	-0.046	0.08	-0.6	-0.22	-0.13	-0.25	-1.65	-0.35	-0.37	-0.24	-0.24	-0.19	-0.37	-0.079	-0.068	-0.061	-0.083	-0.04	-0.041	-0.084	-0.069	-0.057	-0.057
Verwaterde WPA Numbers are in millions	-0.05	-0.032	-0.046	-0.15	-0.6	-0.22	-0.13	-0.25	-1.65	-0.35	-0.37	-0.24	-0.24	-0.19	-0.37	-0.079	-0.068	-0.061	-0.082	-0.039	-0.041	-0.084	-0.069	-0.057	-0.057
EBITDA Numbers are in millions	-7.989	-21.371	-3.958	-7.401	-20.659	-7.697	-4.236	-3.728	-14.518	-5.323	-5.553	-3.634	-3.535	-2.751	-4.715	-0.779	0	-0.717	0	-0.336	-0.342	0	-0.063	0	0
EBITDA ratio Numbers are in millions	0	0	0	0	0	28.402	0	0	-21.508	0	-5.839	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unicycive Therapeutics, Inc.

NASDAQ:UNCY Add to watchlist

NASDAQ:UNCY